1.
Int J Mol Sci
; 22(23)2021 Nov 28.
Article
in English
| MEDLINE
| ID: mdl-34884679
ABSTRACT
The mobilization of endothelial progenitor cells (EPCs) into circulation from bone marrow is well known to be present in several clinical settings, including acute coronary syndrome, heart failure, diabetes and peripheral vascular disease. The aim of this review was to explore the current literature focusing on the great opportunity that EPCs can have in terms of regenerative medicine.